Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PinPrint has developed a proprietary high-resolution 3D printing method called iCLIP that enables the production of precision microneedle patches and microfluidic devices. These patches are designed to deliver vaccines and drugs intradermally as a less invasive alternative to traditional injections. The company has published research validating its approach and has secured at least one large pharma collaboration while seeking additional partners. Recent investment from Continuity Biosciences will help expand into aesthetic/cosmetic drug delivery applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PinPrint.